Skip to main content
Rapid Reactions

Biomarker Testing in mCRC to Help Identify Appropriate Patients for Targeted Treatment

Pashtoon Kasi, MD, MS
Director, Colon Cancer Research, Weill Cornell Medicine
Director, Liquid Biopsy Research, Englander Institute of Precision Medicine
New York, NY
Pashtoon Kasi, MD, MS, from Weill Cornell Medicine and Englander Institute of Precision Medicine, explores potential best practice approaches to biomarker testing in mCRC.

Related Items